MannKind
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MannKind and other ETFs, options, and stocks.About MNKD
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501.
MNKD Key Statistics
Stock Snapshot
With a market cap of 1.28B, MannKind(MNKD) trades at $4.13. The stock has a price-to-earnings ratio of -52.95.
As of 2026-07-25, MannKind(MNKD) stock has fluctuated between $3.98 and $4.23. The current price stands at $4.13, placing the stock +3.8% above today's low and -2.4% off the high.
The MannKind(MNKD)'s current trading volume is 9.44M, compared to an average daily volume of 4.65M.
In the last year, MannKind(MNKD) shares hit a 52-week high of $6.51 and a 52-week low of $2.23.
In the last year, MannKind(MNKD) shares hit a 52-week high of $6.51 and a 52-week low of $2.23.
MNKD News
...
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...
MannKind (MNKD) Jumps On FDA Approval Of Furoscix ReadyFlow The FDA has approved Furoscix ReadyFlow, a furosemide injection designed to treat edema (swelling ca...
Analyst ratings
88%
of 8 ratingsMore MNKD News
H.C. Wainwright views the July 26 FDA action date for the Furoscix ReadyFlow Autoinjector as an “underappreciated catalyst” for MannKind (MNKD) shares. Approval...
MannKind Corporation (MNKD) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more co...
Key Points This MannKind insider filing details the disposition of 46,795 shares. The transaction reduced the insider's direct equity holdings by 9%. The act...
MannKind stock has fallen 28.0% year to date, yet valuation checks suggest the market price may still sit below an estimate of intrinsic value based on a Discou...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.